Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
View Patent ↗A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
1. A process for inhibiting self-repair of nucleic acid of pathogenic white blood cells, bacteria and/or viruses which may be contained in blood components comprising the steps of:
adding to the blood components riboflavin acting as a photosensitizer at a final concentration of between about 50-500 μM;
irradiating the blood components and riboflavin acting as a photosensitizer with light in a visible or UV range at an appropriate wavelength to activate the riboflavin acting as a photosensitizer to fragment the nucleic acid of the pathogenic white blood cells, bacteria and/or viruses to inhibit self-repair of the nucleic acid; and
wherein the inhibition of nucleic acid self-repair caused by the photosensitizer and light is maintained over time such that the pathogenic white blood cells, bacteria and/or viruses will not reproduce in the blood components.
2. The process of claim 1 further comprising adding to the blood components and riboflavin acting as a photosensitizer a solution containing additives to enhance blood component viability.
3. The process of claim 1 wherein the blood component further comprises platelets.
4. The process of claim 1 wherein the blood component further comprises red blood cells.
5. The process of claim 1 wherein the light used to irradiate the blood components and riboflavin acting as a photosensitizer is in the UVB range.